Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Alliance fact sheets


Board Documents


Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update



Geneva, Switzerland, 28-29 April 2005
Summary Report

>>Back to the 15th GAVI Board Meeting

  • Presentation:  Bo Stenson (PPT - 84K)
  • Paper (PDF - 23K
  • 4. Investment Case review process

    • In the future it will be important to provide more background information to the Board so that prior decisions are understood and not revisited.
    • The GAVI Board will be challenged to make difficult decisions about future GAVI investment areas. The process cannot be over-simplified.
    • Some Board members felt that the new vaccine investment cases should be requested for review already in December 2005. However, the majority view was that the new vaccine investment cases should be delayed (see decision 4.4).
    • In cases where global information is not complete, it may be worthwhile exploring whether decisions could be made on a regional basis so that action could be based on information at hand instead of delayed until all information becomes available.

    The Board:

      4.1 Approved the proposed investment case review process including the creation of an independent review group to provide recommendations to the GAVI Board for decision.

      4.2 Agreed to review the proposed review committee members and respond to the Secretariat by email within one week (by 6 May), but requested additional information concerning the reasons why these particular individuals are being proposed.

      4.3 Agreed that the investment cases dependent on IFFIm funding measles, maternal and neonatal tetanus, and polio stockpile should be presented to the Board for decision in July, considering the need to disburse funding quickly should the IFFIm be launched at the G8 Summit in early July.

      4.4 Agreed that new vaccine investment cases should not be submitted in December 2005 but delayed to allow for more time for high-level strategic discussions. Further, the Board will need to judge the vaccine investment cases against the proportion of overall resource envelope.

      4.5 Requested the Working Group to explore the issues relating to the process for solicitation of vaccine investment cases, and submit its recommendations to the GAVI Board at a future meeting.

    >>Back to the 15th GAVI Board Meeting

    View all presentations here


    1. Global Immunization Vision and Strategy (GIVS)
    2. The Vaccine Fund financial forecast
    3. Looking forward to phase 2; GAVI funding principles
    4. Investment Case review process
    5. Advance market mechanisms
    6. The evolving vaccine pipeline
    7. Long-term vaccine procurement strategy
    8. HepB, Hib and yellow fever in phase 2
    9. Update on the Health System Support (HSS) investment case
    10. Update on the International Finance Facility for Immunization (IFFIm)
    11. 2006-07 GAVI strategic framework and work plan
    12. In camera session
    [ star_int ]   Contact us | Guestbook | Copyrights | Illustrated site